Ghidul pentru managementul hipertensiunii arteriale 2007 Grupul ...

More documents

Recommendations

Info

Revista Română de CardiologieVol. XXII, Nr. 3, 2007Ghidul pentru managementul hipertensiunii arteriale 2007Ghid al Societăţii Europene de Cardiologie128. Zarnke KB, Feagan BG, Mahon JL, Feldman RD. A randomized studycomparing a patient-directed hypertension management strategywith usual office-based care. Am J Hypertens 1997;10:58-67. OS.129. PickeringT, James GD, BoddieC, Hrashfield GA, BlankS, Laragh JH.How common is white coat hypertension? JAMA 1988;259:225-228.OS.130. Parati G, Ulian L, Santucci C, Omboni S, Mancia G. Difference betweenclinic and daytime blood pressure is not a measure of the whitecoat effect. Hypertension 1998;31:1185-1189. OS.131. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A,Gregorini L, Zanchetti A. Effects of blood-pressure measurement bythe doctor on patient’s blood pressure and heart rate. Lancet 1983;2:695-698. OS.132. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A.Alerting reaction and rise in blood pressure during measurement byphysician and nurse. Hypertension 1987;9:209-215. OS.133. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term riskof mortality associated with selective and combined elevation in office,home, and ambulatory blood pressure. Hypertension 2006;47:846-853. OS.134. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J,Totsune K, Hoshi H, Satoh H, Imai Y. Prognosis of masked hypertensionand white-coat hypertension detected by 24-h ambulatory blood pressuremonitoring. J Am Coll Cardiol 2005;46:508-515. OS.135. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coatversus sustained mild hypertension. A 10-year follow-up study. Circulation1998;98:1892-1897. OS.136. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, ClementD, de Leeuw PW, Dobovisek J, Jaaskivi M, Leonetti G, O’Brien E,Palatini P, Parati G, Rodicio JL, Vanhanen H, Webster J. Response toantihypertensive treatment in older patients with sustained or nonsustainedsystolic hypertension. Circulation 2000;102:1139-1144. OS.137. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J,Mallion JM. Cardiovascular prognosis of ‘masked hypertension’detected by blood pressure self-measurement in elderly treatedhypertensive patients. JAMA 2004;291:1342-1349. OS.138. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, PickeringTG, Imai Y, Ohkubo T, Kario K. Short- and long-term incidence ofstro ke in white-coat hypertension. Hypertension 2005;45:203-208.OS.139. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R,Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G.Alterations of cardiac structure in patients with isolated office, ambulatoryor home hypertension. Data from the general PAMELA population.Circulation 2001;104:1385-1392. OS.140. Wing LMH, Brown MA, Beilin LJ, Ryan P, Reid C. Reverse white-coathypertension in older hypertensives. J Hypertens 2002; 20:639-644.OS.141. Bjorklund K, Lind L, Zethelius B, Andren B, Lithell H. Isolatedambulatory hypertension predicts cardiovascular morbidity in elderlymen. Circulation 2003;107:1297-1302. OS.142. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen JA.Prevalence, persistence, and clinical significance of masked hypertensionin youth. Hypertension 2005;45:493-498. OS.143. Mancia G, Parati G. Reactivity to physical and behavioral stress andblood pressure variability in hypertension. In: Julius S, Bassett DR.(editors). Handbook of Hypertension. Vol 9. Behavioral Factors inHypertension. Elsevier Sci Publ; 1987. pp. 104-122. RV.144. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, RayCA. American College of Sports Medicine Position Stand: Exerciseand Hypertension. Med Sci Sports Exerc 2004;36:533-553. GL.145. Singh JP, Larson MG, Manolio TA, O’Donnell CJ, Lauer M, Evans JC,Levy D. Blood pressure response during treadmill testing as a riskfactor for new-onset hypertension: the Framingham Heart Study.Circulation 1999;99:1831-1836. OS.146. Carroll D, Smith GD, Shipley MJ, Steptoe A, Brunner EJ, Marmot MG.Blood pressure reactions to acute psychological stress and futureblood pressure status: a 10-year follow-up of men in the Whitehall IIstudy. Psychosom Med 2001;63:737-743. OS.147. Manolio TA, Burke GL, Savage PJ, Sidney S, Gardin JM, Oberman A. Exercise blood pressure response and 5-year risk of elevated blood pressurein a cohort of young adults: the CARDIA study. Am J Hypertens 1994; 7:234-241. CT.148. Fagard R, Staessen J, Amery A. Exercise blood pressure and targetorgan damage in essential hypertension. J Hum Hypertension 1991;5:69-75. OS.149. Filipovsky J, Ducimetiere P, Safar M. Prognostic significance of exerciseblood pressure and heart rate in middle-aged men. Hypertension 1992;20:337-339. OS.150. Lauer MS, Levy D, Anderson KM, Plehn JF. Is there a relationshipbetween exercise systolic blood pressure response and left ventricularmass? Ann Intern Med 1992;116:203-210. OS.151. Smith DHG, Neutel JM, Graettinger WF, Myers J, Froelicher VF,Weber MA. Impact of left ventricular hypertrophy on blood pressureresponses to exercise. Am J Cardiol 1992;69:225-228. OS.152. Fagard R, Staessen J, Thijs L, Amery A. Relation of left ventricular massand filling to exercise blood pressure and rest blood pressure. Am JCardiol 1995;75:53-57. OS.153. Markovitz JH, Raczynski JM, Lewis CE, Flack J, Chesney M, Chettur V,Hardin JM, Johnson E. Lack of independent relationships betweenleft ventricular mass and cardiovascular reactivity to physical andpsy chological stress in the CARDIA study. Am J Hypertens 1996;9:915-923. OS.154. Fagard RH, Pardaens K, Staessen JA, Thijs L. Should exercise bloodpressure be measured in clinical practice? J Hypertens 1998; 16:1215-1217. RV.155. Kokkinos P, Pittaras A, Narayan P, Faselis C, Singh S, Manolis A. Exercisecapacity and blood pressure associations with left ventricular mass inprehypertensive individuals. Hypertension 2007;49:55-61. OS.156. Al’Absi M, Devereux RB, Lewis CE, Kitzman DW, Rao DC, Hopkins P,Markovitz J, Arnett DK. Blood pressure responses to acute stress andleft ventricular mass. Am J Cardiol 2002;89:536-540. OS.157. Rostrup M, Smith G, Bjornstad H, Westheim A, Stokland O, Eide I.Left ven tricular mass and cardiovascular reactivity in young men.Hypertension 1994;23(Suppl I):I168-I171. OS.158. Al’Absi M, Devereux RB, Rao DC, Kitzman D, Oberman A, Hopkins P,Arnett DK. Blood pressure stress reactivity and left ventricular mass ina random community sample of African-American and Caucasianmen and women. Am J Cardiol 2006;97:240-244. OS.159. Fagard RH, Pardaens K, Staessen JA, Thijs L. Prognostic value of invasivehemodynamic measurements at rest and during exercise in hypertensivemen. Hypertension 1996;28:31-36. OS.160. Kjeldsen SE, Mundal R, Sandvik L, Erikssen G, Thaulow E, Erikssen J.Supine and exercise systolic blood pressure predict cardiovasculardeath in middle-aged men. J Hypertens 2001;19:1343-1348. OS.161. Palatini P. Exaggerated blood pressure response to exercise: pathophysiologicmechanisms and clinical relevance. J Sports Med Phys Fitness1998;38:1-9. OS.162. O’ Rourke MF. Principles and definitions of arterial stiffness, wavereflections and pulse pressure amplification. In Safar ME, O’RourkeMF (editors), Arterial stiffness in hypertension. Handbook of Hypertension. Elsevier; 2006.Vol 23:3-19. pp.163. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensivedrug classes on central aortic pressure. Am J Hypertens 2004;17:118-123.164. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformationof radial tonometry pressure. Validation of generalized tran s-fer function. Circulation 1997;95:1827-1836.165. Hope SA, Tay DB, Meredith IT, Cameron JD. Use of arterial transferfunctions for the derivation of aortic waveform characteristics. JHypertens 2003;21:1299-1305.166. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D,Hughes AD, Thurston H, O’Rourke M. CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE SteeringCommittee, Writing Committee. Differential impact of blood pressureloweringdrugs on central aortic pressure and clinical outcomes:principal results of the Conduit Artery Function Evaluation (CAFE)study. Circulation 2006; 113:1213-1225. RT.
Ghidul pentru managementul hipertensiunii arteriale 2007Ghid al Societăţii Europene de Cardiologie167. Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ,Wilkinson IB. Atenolol and eprosartan: differential effects on centralblood pressure and aortic pulse wave velocity. Am J Hypertens 2006;19:214-219. RT.168. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, deBoer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S,Ostergren J, Tuomilehto J, Thrainsdottir I. Task Force on Diabetes andCardiovascular Diseases of the European Society of Cardiology (ESC);European Association for the Study of Diabetes (EASD). Guidelineson diabetes, pre-diabetes, and cardiovascular diseases: executive summary:The Task Force on Diabetes and Cardiovascular Diseases ofthe European Society of Cardiology (ESC) and of the European Associationfor the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136.GL.169. Ridker PM. High-sensitivity C-reactive protein: potential adjunct forglobal risk assessment in the primary prevention of cardiovasculardisease. Circulation 2001;103:1813 1818. OS.170. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C,Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D’Agostino RB,Vasan RS. Multiple biomarkers for the prediction of first majorcardiovascular events and death. N Engl J Med 2006;355:2631-2639.OS.171. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, themetabolic syndrome, and risk of incident cardiovascular events:an 8-year follow-up of 14719 initially healthy American women.Circulation 2003;107:391-397. OS.172. Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM,Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolicsyndrome with and without C-reactive protein as a predictor ofcoronary heart disease and diabetes in the West Of Scotland CoronaryPrevention Study. Circulation 2003;108:414-419. OS.173. Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Hall C, Ibsen H,Rokkedal J, Devereux RB, Hildebrandt P. N-terminal pro-brain natriureticpeptide predicts cardiovascular events in patients with hypertensionand left ventricular hypertrophy: a LIFE study. J Hypertens2004;22:1597-1604. OS.174. Luft FC. Molecular genetics of human hypertension. J Hypertens 1998;16:1871 1878. RV.175. Melander O. Genetic factors in hypertension-what is known and whatdoes it mean? Blood Press 2001;10:254-270. RV.176. Cadman PE, O’Connor DT. Pharmacogenomics of hypertension. CurrOpin Nephrol Hypertens 2003; 12:61-70. RV.177. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of humanhypertension. Cell 2001; 104:545-556. RV.178. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension microalbuminuria risk of ischemicheart disease. Hypertension 2000;35:898-903. OS.179. De Leeuw PW, Ruilope LM, Palmer CR, Brown MJ, Castaigne A,Mancia G, Rosenthal T, Wagener G. Clinical significance of renalfunction in hypertensive patients at high risk: results from theINSIGHT trial. Arch Intern Med 2004; 164:2459-2464. RT.180. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, HammLL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P,Pfeffer M, Raij L, Spinosa DJ, Wilson PW. American Heart AssociationCouncils on Kidney in Cardiovascular Disease, High Blood PressureResearch, Clinical Cardiology, and Epidemiology and Prevention.Kidney disease as a risk factor for development of cardiovasculardisease: a statement from the American Heart Association Councilson Kidney in Cardiovascular Disease, High Blood Pressure Research,Clinical Cardiology, and Epide miology and Prevention. Circulation2003;108:2154-2169. GL.181. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B,Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. HOPE StudyInvestigators. Albuminuria and risk of cardiovascular events, death,and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426. OS.182. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, LindholmLH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U,Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe -PedersenRevista Română de CardiologieVol. XXII, Nr. 3, 2007O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, SnapinnSM, Aurup P. Albuminuria and cardiovascular risk in hypertensivepatients with left ventricular hypertrophy: the LIFE study. Ann InternMed 2003; 139:901 -906. OS.183. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM,Bouter LM, Stehouwer CD. Microalbuminuria and peripheral arterialdisease are independent predictors of cardiovascular and all-causemortality, especially among hypertensive subjects: five-year follow-upof the Hoorn Study. Arterioscler Thromb Vasc Biol 1999;19:617-624.OS.184. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuriapredicts cardiovascular events and renal insufficiency in patients withessential hypertension. J Hypertens 1998;16:1325-1333. OS.185. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, vanVeldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE.Prevention of Renal, Vascular End Stage Disease (PREVEND) StudyGroup. Urinary albumin excretion predicts cardiovascular and noncardiovascularmortality in general population. Circulation 2002;106:1777-1782. OS.186. National Kidney Foundation. Executive summary. Am J Kid Dis 2004;43(Suppl. 1):S16-S33. RV.187. Levy D, Salomon M, D’Agostino RB, Belanger AJ, Kannel WB. Prognosticimplications of baseline electrocardiographic features and theirserial changes in subjects with left ventricular hypertrophy. Circulation1994;90:1786-1793. OS.188. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognosticimplications of echocardiographically determined left ventricularmass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566. OS.189. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relationof left ventricular mass and geometry to morbidity and mortality inuncom plicated essential hypertension. Ann Intern Med 1991;114:345-352. OS.190. Salonen JT, Salonen R. Ultrasound B-mode imaging in observationalstudies of atherosclerotic progression. Circulation 1993;87(Suppl II):II56-II65. OS.191. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Commoncarotid intima-media thickness and risk of stroke and myocardialinfarction: The Rotterdam Study. Circulation 1997;96:1432-1437. OS.192. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP.The role of carotid arterial intima-media thickness in predictingclinical coronary events. Ann Intern Med 1998;128:262-269. OS.193. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, WolfsonSK Jr. Carotid-artery intima and media thickness as a risk factor formyocardial infarction and stroke in older adults. Cardiovascular HealthStudy Collaborative Research Group. N Engl J Med 1999;340:14-22.OS.194. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B,Zanchetti A. Role of echocardiography and carotid ultrasonography instratifying risk in patients with essential hypertension: the Assessmentof Prognostic Risk Observational Survey. J Hypertens 2002;20:1307-1314. OS.195. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS,Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH,Dahlof B. LIFE Study Investigators. Regression of electrocardiographicleft ventricular hypertrophy during antihypertensive treatment andthe prediction of major cardiovascular events. JAMA 2004; 292:2343-2349. OS.196. Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhager WH, BulpittCJ, de Leeuw PW, Leonetti G, Sarti C, Tuomilehto J, Webster J, YodfatY. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.Prognostic significance of electrocardiographic voltages and theirserial changes in elderly with systolic hypertension. Hypertension2004;44:459-464. OS.197. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O,Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E,Cobelli F. Short-term heart rate variability strongly predicts suddencardiac death in chronic heart failure patients. Circulation 2003; 107:565-570. OS.
Page 3 and 4:
Vol. XXII, Nr. 3, 2007EDITORIALARTI
Page 5 and 6:
CONSILIUL DE CONDUCERE ALSOCIETĂŢ
Page 7 and 8:
Revista Română de Cardiologie | V
Page 9 and 10:
Page 11 and 12:
C. Zara şi col.Stenoza subaortică
Page 13 and 14:
Revista Română de CardiologieVol.
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
S. Kontogeorgos şi col.Testul de e
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
M. Rugină şi col.Incidentalom sup
Page 31 and 32:
M. Rugină şi col.Incidentalom sup
Page 33 and 34:
Page 35 and 36:
Actualităţi în cardiologieameric
Page 37 and 38:
Actualităţi în cardiologiepacien
Page 39 and 40:
Page 41 and 42:
Ghidul pentru managementul hiperten
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64: Ghidul pentru managementul hiperten
Page 113: Ghidul pentru managementul hiperten
Page 135: Revista Română de Cardiologie | V
show all

Ghidul pentru managementul hipertensiunii arteriale 2007 Grupul ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?